Please login to the form below

Not currently logged in
Email:
Password:

Kevzara

This page shows the latest Kevzara news and features for those working in and with pharma, biotech and healthcare.

EMA to evaluate Roche arthritis drug RoActemra for severe COVID-19

EMA to evaluate Roche arthritis drug RoActemra for severe COVID-19

Along with Sanofi's Kevzara, Roche’s Actemra was recommended in the World Health Organization’s updated patient care guidelines as a ‘life-saving’ drug for the treatment of COVID-19

Latest news

More from news
Approximately 7 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    Evaluating IL-6 inhibitors: Roche’s Actemra and Sanofi and Regeneron’s Kevzara. Roche, Sanofi and Regeneron are also looking to repurpose their existing treatments and are currently testing their ... Encouraged by this initial data, Sanofi and

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....